About
Blood-protein screening technology for Alzheimer's
Areas of Focus
Categories
DiagnosticsSouthwestern U.S.
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
670
By Phase
NA: 1
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06723275Collaborator
LEOPARD Prospective Validation Cohort 1
N/ANot yet recruiting
630 participants
Started: Jan 31, 2025 · Completed: Oct 31, 2027
NCT04499833Collaborator
HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma
NARecruiting
40 participants
Started: Mar 25, 2021 · Completed: Dec 31, 2029
Locations (1)
Headquarters
Fort Worth, TX, United States
Map
Loading map...